124
Views
0
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Ischaemic versus non-ischaemic: how does heart failure aetiology affect pulmonary arterial capacitance and pulmonary artery pulsatility index in end-stage heart failure?

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 204-210 | Received 19 Apr 2021, Accepted 01 Jul 2021, Published online: 20 Dec 2021

References

  • Voelkel NF, Quaife RA, Leinwand LA, et al.; National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114(17):1883–1891.
  • Haddad F, Doyle R, Murphy DJ, et al. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117(13):1717–1731.
  • Mandras SA, Desai S. Right heart failure. StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC.; 2018.
  • Juilliere Y, Buffet P, Marie PY, et al. Comparison of right ventricular systolic function in idiopathic dilated cardiomyopathy and healed anterior wall myocardial infarction associated with atherosclerotic coronary artery disease. Am J Cardiol. 1994;73(8):588–590.
  • Iskandrian AS, Helfeld H, Lemlek J, et al. Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy based on right ventricular performance. Am Heart J. 1992;123(3):768–773.
  • La Vecchia L, Zanolla L, Varotto L, et al. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction. Am Heart J. 2001;142(1):181–189.
  • Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–1084.
  • Mehra MR, Canter CE, Hannan MM, International Society for Heart Lung Transplantation (ISHLT) Infectious Diseases, Pediatric and Heart Failure and Transplantation Councils, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35(1):1–23.
  • Dragu R, Rispler S, Habib M, et al. Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension. Eur J Heart Fail. 2015;17(1):74–80.
  • Dupont M, Mullens W, Skouri HN, et al. Prognostic role of pulmonary arterial capacitance in advanced heart failure. Circ: Heart Failure. 2012;5(6):778–785.
  • Sugimoto K, Yoshihisa A, Nakazato K, et al. Pulmonary arterial capacitance predicts cardiac events in pulmonary hypertension due to left heart disease. PLoS One. 2016;11(11):e0165603.
  • Mahapatra S, Nishimura RA, Sorajja P, et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol. 2006;47(4):799–803.
  • Korabathina R, Heffernan KS, Paruchuri V, et al. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. Cathet Cardiovasc Intervent. 2012;80(4):593–600.
  • Kang G, Ha R, Banerjee D. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant. 2016;35(1):67–73.
  • Morine KJ, Kiernan MS, Pham DT, et al. Pulmonary artery pulsatility index is associated with right ventricular failure after left ventricular assist device surgery. J Cardiac Failure. 2016;22(2):110–116.
  • Wasemiller S, Earle T, Kashner M, et al. Right ventricular ejection fraction in ischemic versus nonischemic cardiomyopathy. Am J Cardiol. 2016;117(2):278–281.
  • Baumgartner H, Falk V, Bax JJ, ESC Scientific Document Group, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
  • Condon DF, Nickel NP, Anderson R, et al. The 6th World Symposium on Pulmonary Hypertension: what's old is new. F1000Res. 2019;8:888.
  • Pellegrini P, Rossi A, Pasotti M, et al. Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest. 2014;145(5):1064–1070.
  • Tsiouris A, Borgi J, Karam J, et al. Ischemic versus nonischemic dilated cardiomyopathy: the implications of heart failure etiology on left ventricular assist device outcomes. ASAIO J. 2013;59(2):130–135.
  • Cesini S, Bhagra S, Pettit SJ. Low pulmonary artery pulsatility index is associated with adverse outcomes in ambulatory patients with advanced heart failure. J Card Fail. 2020;26(4):352–359.
  • Kochav SM, Flores RJ, Truby LK, et al. Prognostic impact of pulmonary artery pulsatility index (papi) in patients with advanced heart failure: insights from the ESCAPE trial. J Cardiac Failure. 2018;24(7):453–459.
  • Neyer J, Arsanjani R, Moriguchi J, et al. Echocardiographic parameters associated with right ventricular failure after left ventricular assist device: a review. J Heart Lung Transplant. 2016;35(3):283–293.
  • Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail. 2010;12(5):434–443.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.